FDA Requests Comment on International Scheduling of Synthetic Cannabinoids, Other Drugs

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

International Cooperation

FDA Requests Comment on International Scheduling of Synthetic Cannabinoids, Other Drugs

Ken Baumgartner

September 11, 2019 at 21:32:40 ET

The U.S. Food and Drug Administration published a notice and request for comments on pending international drug scheduling under the Convention of Psychotropic Drugs and the Convention on Narcotic Drugs (84 Fed. Reg. 47521, Sept. 10, 2019). The drugs under consideration for international control are APINACA, AB-FUBINACA, 5F-AMB, 5F-MDMB-PICA, 4-F-MDMB-PICA (all synthetic cannabinoi... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

FDA Requests Comment on International Scheduling of Synthetic Cannabinoids, Other Drugs

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT